Zum Hauptinhalt springen
journal: Frigid Zone Medicine
Zeitschrift Open Access

Frigid Zone Medicine

Sprache: Englisch
Erstveröffentlichung: 20. März 2021

Über diese Zeitschrift

About this journal

Frigid Zone Medicine, a high-quality, open access, medical journal in the English language, starts the first issue in 2021. The journal is managed by the Heilongjiang Health Commission, organized by the Heilongjiang Health Development Research Center and cooperated with Scholar Media Publishing.

This journal publishes articles on the latest research results and leading developments in the field of Frigid Zone medicine, providing an international academic platform for local and overseas researchers of the related field. The journal aspires to increase the quality of regional and national health research. It aims at building a qualified international medical platform for academic communication and development, leading the academic studies and practices, promoting the international clinical researches and experiments of Frigid Zone, and improving the academic impact in this field.

According to the latest research, Frigid Zone Medicine defines the field of Frigid Zone as the regions with an average temperature below 0℃ in t he winter. In the definition, many parts of the world are covered as places with cold weather. The journal is willing to explore the health-related research and reports in regions with cold weather, aiming at recognizing and exploring the health-related problems in regions with cold weather, encouraging more research on the treatment of diseases caused by cold weather, promoting the health development and communication on the health-related research of the cold regions, and advocating the health-related quality of residents in these areas. Frigid Zone Medicine keeps health care professionals at the leading edge of medical knowledge, helps them to gain broad understanding in their areas of interest, and provides a variety of engaging and innovative ways to communicate.

The editorial committees are selected from an international pool of researchers with high levels of achievement and recognition in their fields, having stellar reputations in their disciplines. The editorial committee of this journal co mprises of scientists from across the world.

The mission of Frigid Zone Medicine is to provide fair, fast, and expert peer review to authors and a vetted selection of research, freely available to readers. The journal follows a double-blind review process, wherein the reviewers and authors are unaware of each other’s identity. The journal fosters the advance of the clinical practice and health research. The column consists of disease study, academic communication, expert forum, international dynamics and references. The scope of the journal encompasses international medical specialists’ reviews, clinical guidance, clinical commentaries, special comments, clinical reports, research reports, case study reports, short communications, correspondence and technical progress, etc.

Frigid Zone Medicine welcomes submissions from all fields of health and from any source. The journal invites submissions on topics pertaining to health-related research in cold regions, including but not limited to non-co mmunicable diseases, internal medicine, basic medical science, mental disease, cardiology, rheumatology, pneumology, angiology, altitude stress, frostbite, aging health, and health policy.

Aiming at high-level international journals, Frigid Zone Medicine strictly complies with the international disciplines and strategies of the editing and publication. It closely follows the industry associations. The journal is committed to meeting and upholding standards of ethical behavior at all stages of the publication process. It follows the peer-review process, and the reviewers are internationally renowned experts. It provides editorial, peer, and statistical review processes to evaluate manuscripts for scientific accuracy, novelty, and importance.

Frigid Zone Medicine is published internationally, and all articles published in this journal are made freely and permanently accessible online. Frigid Zone Medicine is a quarterly journal, with 64 pages and color cover. It covers subjects of basic medica l science and clinical medicine. The publications, in print and online, reach a truly worldwide audience. Editorial Manager, Online Publishing Platform, and Advance Online Publication (AOP) are applied. Research in our journals is given extra accessibility and depth through commentaries, reviews, and editorial summaries.

Frigid Zone Medicine will start publication in 2020. At the beginning of the development, it has received the project of "High Beginning New Journal" supported by the China Association for Science and Technology. This journal is managed by a research center with a long history of managing a group of journals in varied medical fields. The facilitated research center has appropriative cooperation, which has well reputation and basement in developing journals, providing excellent publishing resources.

Frigid Zone Medicine invites contributions all over the world.

Please submit your manuscript at www.editorialmanager.com/fzm/, where you will be guided through the peer reviewing and submission process.

If you have any other question, please contact the Editorial Office at: fzm@frigidzonemedicine.com.

Articles published in Volume 1 (2021) to Volume 3 (2023) were published under CC BY-NC-ND  license, starting from Volume 4 (2024) all articles are published under CC BY licence.

Your benefits of publishing with us

Submission process

  • Please format your manuscript according to the Information for Authors and the Author statement
  • Manuscripts must be written in clear and concise English.
  • The journal operates a double-blind peer review process
  • The reviewing process takes on average two months. Submissions are sent to 2–3 reviewers. You will be informed by e-mail if your manuscript has been accepted or rejected or if it requires further attention. Every effort is made to respond to authors in a timely manner

Please note

We look forward to receiving your manuscript!

Editor-in-Chief

Baofeng Yang, Harbin Medical University, Harbin, China

Stanley Nattel, Montreal Heart Institute, Montreal, Canada

Deputy Editors-in-Chief

Ye Tian, Harbin Medical University, Harbin, China

Yong Zhang, Harbin Medical University, Harbin, China

Yongchen Wang, The Second Affiliated Hospital of Harbin Medical University, Harbin, China

Yue Li, The First Affiliated Hospital of Harbin Medical University, Harbin, China

Zhengwei Pan, Harbin Medical University, Harbin, China

Editorial Board Members

Andreas Papapetropoulos, National and Kapodistrian University of Athens, Athens, Greece

Bo Yu, The Second Affiliated Hospital of Harbin Medical University, Harbin, China

Danfeng Yang, Institute of Environmental and Operation Medicine, Academy of Military Medical Sciences, Academy of Military Sciences, Beijing, China

Deyou Jiang, Heilongjiang University of Chinese Medicine, Harbin, China

Edita Margaryan, Sechenov First Moscow State Medical University, Moscow, Russia

Gautam Sethi, Department of Pharmacology, National University of Singapore, Singapore City, Singapore

Irina Makeeva, Sechenov University, Moscow, Russia

Jianping Xu, Peking Union Medcial College Hospital, Beijing, China

Jinsong Bian, Southern University of Science and Technology, Shenzhen, China

Jinxin Bei, Sun Yat-sen University Cancer Center, Guangzhou, China

Jun Yu, Johns Hopkins University School of Medicine, Baltimore, US

Kun Huang, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Le Li, The University of Texas MD Anderson Cancer Center, Houston, US

Lei Yang, The First Affiliated Hospital of Harbin Medical University, Harbin, China

Liangdan Sun, North China University of Science and Technology, Tangshan, China

Ling Yang, Shanghai Universty of Traditional Chinese Medicine, Shanghai, China

Lixia Yue, University of Connecticut School of Medicine, Farmington, US

Luwen Zhu, Heilongjiang University of Traditional Chinese Medicine, Harbin, China

Malov Igor, Irkutsk State Medical University, Irkutsk, Russia

Matthew Whiteman, University of Exeter Medical School, Exeter, UK

Rui Wang, York University, Toronto, Canada

Sergey Efetov, IM Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia

Wei Wang, Edith Cowan University, Perth, Australia

Weidong Zhang, Naval Medical University, Shanghai, China

Xi Yang, University of Manitoba, Winnipeg, Canada

Yue Yuan, Baylor College of Medicine, Houston, US

Zheng Liu, Cancer Hospital Chinese Academy of Medcial Sciences, Beijing, China

Managing Editor

Guodong Liu, Heilongjiang Health Development Research Center, Harbin, China

Yangang Ren, Peking University Health Science Center, Harbin, China

Editors

Xiaoxiao Wang, Heilongjiang Health Development Research Center, Harbin, China

Xize Wang, Heilongjiang Health Development Research Center, Harbin, China

Yue Yuan, Harbin Medical University, Harbin, China

Frigid Zone Medicine ist in den folgenden Services indiziert:

  • Baidu Scholar
  • CNKI Scholar (China National Knowledge Infrastructure)
  • CNPIEC - cnpLINKer
  • Dimensions
  • DOAJ (Directory of Open Access Journals)
  • EBSCO Discovery Service
  • Google Scholar
  • J-Gate
  • Naver Academic
  • Naviga (Softweco)
  • Primo Central (ExLibris)
  • ReadCube
  • ScienceON (Korea Institute of Science and Technology Information)
  • Scilit
  • Semantic Scholar
  • Sherpa/RoMEO
  • Summon (ProQuest)
  • TDNet
  • Ulrich's Periodicals Directory/ulrichsweb
  • WanFang Data
  • WorldCat (OCLC)
  • X-MOL
  • Yewno Discover

Zeitschriften Informationen
Weitere Informationen
eISSN:
2719-8073
Sprache:
Englisch
Verlag:
De Gruyter Open Access
Weitere Informationen
Erstveröffentlichung:
20. März 2021
Heruntergeladen am 4.5.2026 von https://www.degruyterbrill.com/journal/key/fzm/html?lang=de
Button zum nach oben scrollen